Show simple item record

dc.contributor.authorCazzola, Mario
dc.contributor.authorBeeh, Kai M
dc.contributor.authorPrice, David
dc.contributor.authorRoche, Nicolas
dc.date.accessioned2015-05-06T15:11:02Z
dc.date.available2015-05-06T15:11:02Z
dc.date.issued2015-04
dc.identifier50089438
dc.identifier2109e62d-e7bb-4f61-b042-12b63f132535
dc.identifier25727846
dc.identifier84926395769
dc.identifier.citationCazzola , M , Beeh , K M , Price , D & Roche , N 2015 , ' Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD ' , Pulmonary pharmacology & therapeutics , vol. 31 , pp. 68-78 . https://doi.org/10.1016/j.pupt.2015.02.007en
dc.identifier.issn1522-9629
dc.identifier.urihttp://hdl.handle.net/2164/4515
dc.descriptionDate of Aceptance: 12/02/2015 Acknowledgments The authors were assisted in the preparation of the manuscript by Sarah Filcek, a professional medical writer at CircleScience (Tytherington, UK), part of KnowledgePoint360, an Ashfield Company. This assistance was funded by Novartis Pharmaceuticals. Copyright © 2015. Published by Elsevier Ltd.en
dc.format.extent11
dc.format.extent583411
dc.language.isoeng
dc.relation.ispartofPulmonary pharmacology & therapeuticsen
dc.subjectadherenceen
dc.subjectbeta-2-adrenergic agonistsen
dc.subjectchronic obstructive pulmonary diseaseen
dc.subjectlong-acting bronchodilatorsen
dc.subjectmuscarinic agonistsen
dc.subjectonset of actionen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subject.lccRMen
dc.titleAssessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPDen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.description.statusPeer revieweden
dc.identifier.doi10.1016/j.pupt.2015.02.007


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record